Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Senores Pharmaceuticals Ltd

NSE: SENORES · BSE: 544319 · Pharmaceuticals & Biotechnology · 40 announcements

Share price
₹1,389.60
Market cap
₹6,400 Cr
Revenue (annual)
₹632.6 Cr
Net profit (annual)
₹115.4 Cr
P/E (TTM)
50.6×Sector 47.3×
Promoter holding
45.82%+0.00% QoQ
FII holding
6.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

17:42 IST BSE
Debt & Borrowing

Senores Pharmaceuticals Debt & Borrowing: ₹62 Cr

Senores Pharmaceuticals has issued a ₹62 Crore corporate guarantee to ICICI Bank to secure credit facilities for its subsidiary, Apnar Pharma Private Limited.

Value
₹62.00 Cr
16:23 IST BSE
Debt & Borrowing

Senores Pharmaceuticals Debt & Borrowing: ₹54.07 Cr

Senores Pharmaceuticals Limited confirmed it does not meet the SEBI criteria for a 'Large Corporate' as of March 31, 2026. The company reported outstanding borrowings of ₹54.07 Crore for the period ended March 31, 2025. This disclosure is part of routine regulatory compliance regarding debt security issuance frameworks.

Value
₹54.07 Cr